[CH:1]1([N:4]2[C:8]([C:9]([O:11][CH2:12][CH3:13])=[O:10])=[CH:7][C:6]([C:14]([F:17])([F:16])[F:15])=[N:5]2)[CH2:3][CH2:2]1.[Cl:18][C:19]1[CH:26]=[CH:25][C:22]([CH:23]=[O:24])=[CH:21][CH:20]=1>CCCCCC>[Cl:18][C:19]1[CH:26]=[CH:25][C:22]([CH:23]([OH:24])[C:7]2[C:6]([C:14]([F:17])([F:16])[F:15])=[N:5][N:4]([CH:1]3[CH2:3][CH2:2]3)[C:8]=2[C:9]([O:11][CH2:12][CH3:13])=[O:10])=[CH:21][CH:20]=1The title compound was prepared in analogy to the procedure described in Step 40.2 using ethyl 1-cyclopropyl-3-(trifluoromethyl)-1H-pyrazole-5-carboxylate (Step 44.1) and 4-chlorobenzaldehyde. tR: 1.29 min (LC-MS 2); ESI-MS: 389 [M+H]+ (LC-MS 2); Rf=0.12 (hexane/15% EtOAc).